Patient reported outcomes (PROs) can be valuable in supporting the reimbursement processes and informing health agencies about new targeted therapies for better management, but lack of awareness about PROs and use of unvalidated PROs present a significant gap in the research of HNC.
This poster, presented at ISPOR 2023, evaluates utilization of PROs in real-world (RW) setting for supporting reimbursement, and framing health policies in HNCs, and explores how utilization of PROs at different stages may lead to better patient care.
